LOX and LOXL2 inhibitors and uses thereof
US10494443B2 · kind B2 · utility
0Cited by
89References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 2, 2016 |
| Grant date | Dec 3, 2019 |
| Priority date | — |
| Expiry date | Nov 2, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/90633
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application relates to anti-LOX and anti-LOXL2 antibodies and their use in purification, diagnostic and therapeutic methods. Antibodies include monoclonal antibodies, humanized antibodies and functional fragments thereof. Anti-LOX and anti-LOXL2 antibodies can be used to identify and treat conditions such as a fibrotic condition, angiogenesis, or to prevent a transition from an epithelial cell state to a mesenchymal cell state.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.